HER2 amplification in squamous cell carcinomas of the vulva

HistopathologyVolume 62, Issue 6 p. 965-967 Correspondence HER2 amplification in squamous cell carcinomas of the vulva Matthias Choschzick, Matthias Choschzick Department of Pathology, University Medical Centre Hamburg-Eppendorf, Hamburg, GermanySearch for more papers by this authorStephan Hess, Stephan Hess Department of Pathology, University Medical Centre Hamburg-Eppendorf, Hamburg, GermanySearch for more papers by this authorTobias Grob, Tobias Grob Department of Pathology, University Medical Centre Hamburg-Eppendorf, Hamburg, GermanySearch for more papers by this authorEike Burandt, Eike Burandt Department of Pathology, University Medical Centre Hamburg-Eppendorf, Hamburg, GermanySearch for more papers by this authorLinn Wölber, Linn Wölber Department of Gynaecology, University Medical Centre Hamburg-Eppendorf, Hamburg, GermanySearch for more papers by this authorRonald Simon, Ronald Simon Department of Pathology, University Medical Centre Hamburg-Eppendorf, Hamburg, GermanySearch for more papers by this authorGuido Sauter, Guido Sauter Department of Pathology, University Medical Centre Hamburg-Eppendorf, Hamburg, GermanySearch for more papers by this author Matthias Choschzick, Matthias Choschzick Department of Pathology, University Medical Centre Hamburg-Eppendorf, Hamburg, GermanySearch for more papers by this authorStephan Hess, Stephan Hess Department of Pathology, University Medical Centre Hamburg-Eppendorf, Hamburg, GermanySearch for more papers by this authorTobias Grob, Tobias Grob Department of Pathology, University Medical Centre Hamburg-Eppendorf, Hamburg, GermanySearch for more papers by this authorEike Burandt, Eike Burandt Department of Pathology, University Medical Centre Hamburg-Eppendorf, Hamburg, GermanySearch for more papers by this authorLinn Wölber, Linn Wölber Department of Gynaecology, University Medical Centre Hamburg-Eppendorf, Hamburg, GermanySearch for more papers by this authorRonald Simon, Ronald Simon Department of Pathology, University Medical Centre Hamburg-Eppendorf, Hamburg, GermanySearch for more papers by this authorGuido Sauter, Guido Sauter Department of Pathology, University Medical Centre Hamburg-Eppendorf, Hamburg, GermanySearch for more papers by this author First published: 28 June 2013 https://doi.org/10.1111/his.12090Citations: 2Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Gutierrez C, Schiff R. HER2: biology, detection, and clinical implications. Arch. Pathol. Lab. Med. 2011; 135; 55–62. 2Woelber L, Kock L, Gieseking F et al. Clinical management of primary vulvar cancer. Eur. J. Cancer 2011; 47; 2315–2321. 3Growdon WB, Boisvert SL, Akhavanfard S et al. Decreased survival in EGFR gene amplified vulvar carcinoma. Gynecol. Oncol. 2008; 111; 289–297. 4Woelber L, Hess S, Bohlken H et al. EGFR gene copy number increase in vulvar carcinomas is linked with poor clinical outcome. J. Clin. Pathol. 2012; 65; 133–139. 5Del Campo JM, Hitt R, Sebastian P et al. Effects of lapatinib monotherapy: results of a randomised Phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck. Br. J. Cancer 2011; 105; 618–627. 6Fekrazad R, Hakimiha N, Farokhi E et al. Treatment of oral squamous cell carcinoma using anti-HER2 immunonanoshells. Int. J. Nanomed. 2011; 6; 2749–2755. Citing Literature Volume62, Issue6May 2013Pages 965-967 ReferencesRelatedInformation